Should the penicillin allergy be removed from the patient’s record after she tolerated two doses of piperacillin‑tazobactam (Zosyn) without any reaction?

No, the penicillin allergy should NOT be automatically removed based solely on tolerating two doses of Zosyn

Tolerating piperacillin-tazobactam does not definitively rule out penicillin allergy and does not justify immediate delabeling without proper evaluation. While this tolerance is reassuring, the FDA explicitly contraindicates Zosyn in patients with penicillin allergy 1, and emerging evidence shows piperacillin-tazobactam has unique immunologic properties that make it an unreliable test for broader penicillin allergy.

Why Zosyn Tolerance Doesn't Equal Penicillin Delabeling

Distinct Immunologic Profile

Piperacillin-tazobactam has a different R1 side chain compared to other penicillins, resulting in lower cross-reactivity 2. This means:

• Patients can tolerate piperacillin-tazobactam while remaining allergic to other penicillins
• Up to one-third of patients with confirmed piperacillin-tazobactam allergy show cross-sensitization to other penicillins, but many are selectively sensitized 3
• The negative predictive value of piperacillin-tazobactam tolerance for other penicillin allergies is unknown

Piperacillin-Tazobactam Has Exceptionally High True Allergy Rates

Unlike typical penicillin allergies (where 90-95% are false), piperacillin-tazobactam shows:

• Up to 32% genuine allergy rate in suspected cases 4
• Poor negative predictive value of skin testing (only 71.9%) 4
• Both immediate and delayed hypersensitivity reactions occur with equal frequency (54% vs 45%) 3

Risk of Delayed Sensitization

Critical safety concern: Anaphylaxis can occur after multiple tolerated doses 5. The sensitization phase may remain occult throughout treatment, meaning two uneventful doses do not guarantee future tolerance.

Proper Delabeling Pathway

Step 1: Obtain Detailed Reaction History

Determine if the original penicillin reaction was:

• Non-allergic (headache, nausea, diarrhea, family history only) → Can delabel immediately without testing 6
• Low-risk delayed (mild rash >72 hours after exposure, remote history >10 years)
• High-risk immediate (anaphylaxis, angioedema, urticaria <1 hour after exposure)
• Severe cutaneous (Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS)

Step 2: Risk-Stratified Approach

For clearly non-allergic reactions:

• Remove label immediately after counseling 6
• Optional single-dose amoxicillin challenge if patient anxious 6

For low-risk reactions:

• Direct oral amoxicillin challenge (single treatment dose) without skin testing 6
• If tolerated, remove penicillin allergy label

For high-risk immediate reactions or recent reactions:

• Refer to allergy specialist for penicillin skin testing 6
• If skin test negative, proceed to oral challenge
• Only delabel after negative testing AND successful challenge

For severe cutaneous reactions:

• Do NOT attempt delabeling
• Permanent contraindication to all penicillins

Step 3: Document Properly

If delabeling after appropriate evaluation:

• Document the specific testing performed
• Note which penicillins were challenged
• Update allergy list to reflect "Penicillin allergy ruled out [date]"

Critical Pitfalls to Avoid

1. Never assume cross-tolerance: Piperacillin-tazobactam tolerance does not predict tolerance to amoxicillin, ampicillin, or other penicillins 3

2. Don't ignore the FDA contraindication: Zosyn labeling explicitly contraindicates use in penicillin-allergic patients 1. Administering it to a labeled penicillin-allergic patient carries medicolegal risk

3. Beware of tazobactam allergy: Some patients may be allergic to the beta-lactamase inhibitor component rather than piperacillin itself 3, further complicating interpretation

4. Two doses are insufficient: Sensitization can develop during treatment, with anaphylaxis occurring after multiple tolerated doses 5, 7

Recommended Action for This Patient

Refer to allergy/immunology for formal penicillin allergy evaluation 6, 8. The proper delabeling process requires:

• Detailed history to determine if original reaction was truly allergic
• Penicillin skin testing if indicated based on reaction type
• Supervised oral amoxicillin challenge
• Only then can the penicillin allergy label be safely removed

The fact that she tolerated Zosyn is valuable information suggesting lower risk, but it does not replace the validated delabeling pathway endorsed by CDC, allergy/immunology societies, and infectious disease societies 6.